Skip to navigation
Skip to content
MU Logo
University of Missouri
Directory
News
Alumni
Give
Search
search
School of Law
menu
About
expand_more
About Mizzou Law
Message from the Dean
Traditions
Mizzou Law Trailblazers
Our Community
Policies and Guidelines
Consumer Information (ABA Required Disclosures)
Admissions
expand_more
Admissions Overview
Apply
Visit
Tuition & Financial Aid
Entering Class Profile
Recruitment Events
Student Ambassadors
Academics
expand_more
Academics Overview
JD Program
LLM Programs
Dual Degrees
Tax Law Program
Health Law Program
Certificates
Undergraduate Studies
Academic Calendar
Clinics
Centers
Study Abroad
Law Journals
Faculty & Research
expand_more
Faculty & Research Overview
Faculty Job Openings
Faculty Blogs
Faculty Speaker Series
Current Students
expand_more
Current Students
Bar Examination Prep
Student Organizations
Student Health and Well-Being
Our Community
One Read
Grades, Ranks & Honors
Policies and Guidelines
Career Services
expand_more
Career Services Overview
Student Career Resources
Alumni Career Resources
Employer Resources
Law Library
expand_more
Law Library Overview
Library Hours
Ask a Librarian
Student Library Resources
Faculty Library Resources
Visitor Library Resources
Law Library Policies
Home
Publications
How Should FDA Use Naming and Labeling to Communicate Information about Biosimilars?
How Should FDA Use Naming and Labeling to Communicate Information about Biosimilars?
FDLI FOOD AND DRUG POLICY FORUM vol.1:no.21 (2011)
Faculty
Erika Lietzan
Databases